Portal vein thrombosis: A predictable milestone in cirrhosis?

Journal of Hepatology

Volumn 51, Issue 4, 2009, Pages 632-634

  Garcia Pagan, Juan Carlos ^a   Valla, Dominique Charles ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

BLOOD CLOTTING DISORDER; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EDITORIAL; GENE MUTATION; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ANTICOAGULANTS; BLOOD COAGULATION DISORDERS, INHERITED; BLOOD FLOW VELOCITY; HUMANS; LIVER CIRRHOSIS; PORTAL VEIN; PROGNOSIS; RISK FACTORS; VENOUS THROMBOSIS;

EID: 70149122110     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.06.009     Document Type: Editorial

References (27)

1. Yerdel M.A., Gunson B., Mirza D., Karayalcin K., Olliff S., Buckels J., et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 69 (2000) 1873-1881
2. Nonami T., Yokoyama I., Iwatsuki S., and Starzl T.E. The incidence of portal vein thrombosis at liver transplantation. Hepatology 16 (1992) 1195-1198
3. Amitrano L., Guardascione M.A., Brancaccio V., Margaglione M., Manguso F., Iannaccone L., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 40 (2004) 736-741
4. Amitrano L., Brancaccio V., Guardascione M.A., Margaglione M., Sacco M., Martino R., et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 34 (2002) 535-538
5. Amitrano L., Brancaccio V., Guardascione M.A., Margaglione M., Iannaccone L., D'Andrea G., et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31 (2000) 345-348
6. Francoz C., Belghiti J., Vilgrain V., Sommacale D., Paradis V., Condat B., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 54 (2005) 691-697
7. Erkan O., Bozdayi A.M., Disibeyaz S., Oguz D., Ozcan M., Bahar K., et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 17 (2005) 339-343
8. Mangia A., Villani M.R., Cappucci G., Santoro R., Ricciardi R., Facciorusso D., et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 17 (2005) 745-751
9. Zocco M.A., Di Stasio E., De Cristofaro R., Novi M., Ainora M.E., Ponziani F., et al. Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51 (2009) 682-689
10. Siringo S., Bolondi L., Gaiani S., Sofia S., Zironi G., Rigamonti A., et al. Timing of the first variceal hemorrhage in cirrhotic patients: prospective evaluation of Doppler flowmetry, endoscopy and clinical parameters. Hepatology 20 (1994) 66-73
11. Merkel C., Sacerdoti D., Bolognesi M., Bombonato G., and Gatta A. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. J Hepatol 28 (1998) 622-630
12. Bolognesi M., Sacerdoti D., Mescoli C., Bombonato G., Cillo U., Merenda R., et al. Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters. Scand J Gastroenterol 42 (2007) 256-262
13. Guyatt G. Determining prognosis and creating clinical decision rules. In: Haynes B., Sackett D.L., Guyatt G., and Tulliez M. (Eds). Clinical epidemiology. 3rd ed. (2006), Lippincott Williams & Wilkins 323-355
14. Gaiani S., Bolondi L., Li B.S., Zironi G., Siringo S., and Barbara L. Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology 100 (1991) 160-167
15. Walker A.P. Portal vein thrombosis: what is the role of genetics?. Eur J Gastroenterol Hepatol 17 (2005) 705-707
16. Bombeli T., Basic A., and Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 70 (2002) 126-132
17. Price D.T., and Ridker P.M. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 127 (1997) 895-903
18. Wanless I.R., Wong F., Blendis L.M., Greig P., Heathcote E.J., and Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 21 (1995) 1238-1247
19. Valla D.C. Thrombosis and anticoagulation in liver disease. Hepatology 47 (2008) 1384-1393
20. Webster G.J., Burroughs A.K., and Riordan S.M. Review article: portal vein thrombosis - new insights into aetiology and management. Aliment Pharmacol Ther 21 (2005) 1-9
21. Northup P.G. Hypercoagulation in liver disease. Clin Liver Dis 13 (2009) 109-116
22. Tripodi A., and Mannucci P.M. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 46 (2007) 727-733
23. Tripodi A., Salerno F., Chantarangkul V., Clerici M., Cazzaniga M., Primignani M., et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 41 (2005) 553-558
24. Valla D.C., and Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 32 (2000) 865-871
25. Denninger M.H., Chait Y., Casadevall N., Hillaire S., Guillin M.C., Bezeaud A., et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31 (2000) 587-591
26. Garcia-Pagan J.C., De Gotardi A., and Bosch J. Review article: the modern management of portal hypertension - primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther 28 (2008) 178-186
27. Bosch J., Mastai R., Kravetz D., Bruix J., Gaya J., Rigau J., et al. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 4 (1984) 1200-1205